ENTITY

ABLBio (298380 KS)

4

Analysis

Health Care • South Korea

ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.

more

Refresh

Exchange Announcement • 28 Oct 2024 10:23

Material Management Information related to Judgment of Investment(ABL301 ê´ë ¨ ë§ì¼ì¤í¤ ê¸°ì ë£ ìë ¹)

Exchange Announcement • 23 Oct 2024 10:55

Material Management Information related to Judgment of Investment(ì ê· íì²´ì½ë¬¼ ê²°í©ì²´(ADC) ì°êµ¬ê°ë°ì ìí ê¸°ì ëì ê³ì½ ì²´ê²°)

Exchange Announcement • 30 Aug 2024 17:20

Material Management Information related to Judgment of Investment(Study Results)(ì´ì¤íì²´ ë©´ìíìì ABL501ì êµë´ ì 1ì ìììí ê²°ê³¼)

Exchange Announcement • 05 Apr 2024 16:39

New Facilities Investment, etc.

Exchange Announcement • 29 Mar 2024 14:51

Outcomes of Annual Meeting of Shareholders

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x